监禁
发表于 2025-3-23 13:47:15
http://reply.papertrans.cn/28/2707/270647/270647_11.png
他很灵活
发表于 2025-3-23 17:53:45
Mixed Connective Tissue Diseasee major cause of death in these patients is pulmonary hypertension, followed by infections..A debate is still open on whether MCTD represent a distinct clinical entity or rather an overall between different established connective tissue diseases (CTDs). The answer to this question might become clear
DUST
发表于 2025-3-23 19:31:26
Raynaud Phenomenonasoregulation of Raynaud phenomenon. This has opened promising therapeutic avenues, and it is likely that therapies targeted toward specific pathophysiological steps become available in the near future.
动作谜
发表于 2025-3-24 01:46:45
The Multiple Autoimmune Syndromess syndrome, and autoimmune thyroid disease as the “chaperones” of autoimmune diseases. FA is defined as the presence of diverse autoimmune diseases on multiple members of a nuclear family. In this chapter, both the MAS and FA are discussed and illustrated in the context of the common genetic backgro
注射器
发表于 2025-3-24 03:19:29
http://reply.papertrans.cn/28/2707/270647/270647_15.png
HEPA-filter
发表于 2025-3-24 09:17:27
Takayasu Arteritisly angiotomography or angioresonance. The following criteria are suggestive of the disease: (a) the concomitant presence of stenosis and aneurysm in aorta, (b) presence of stenosis of at least one aortic branch such as subclavian, common carotid, inonimate, vertebral, renal or mesenteric, especially
Bouquet
发表于 2025-3-24 13:04:58
Polyarteritis Nodosaose corticosteroids, which are combined with immunosuppressive agents when critical organ involvement or life-threatening complications occur. IV pulse cyclophosphamide in the remission induction phase, later switched to a safer immunosuppressant for remission maintenance, is a frequently used thera
死猫他烧焦
发表于 2025-3-24 17:32:41
http://reply.papertrans.cn/28/2707/270647/270647_18.png
改进
发表于 2025-3-24 19:24:05
http://reply.papertrans.cn/28/2707/270647/270647_19.png
tympanometry
发表于 2025-3-24 23:40:53
https://doi.org/10.1007/978-94-011-0247-6phase reaction. Other conditions that may mimic polymyalgia rheumatica must be excluded by appropriate testing and close monitoring of the disease course. Glucocorticoids at low doses (15–20 mg/day initially) are the mainstay of treatment.